Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Paratek Pharmaceuticals Opens New HQ in Boston | Contract Pharma

What are you searching for?

Sign in
Breaking News

Paratek Pharmaceuticals Opens New HQ in Boston

Recently initiated a global Phase 3 program for omadacycline

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Paratek Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, opened its new corporate headquarters in Boston at 75 Park Plaza.

“This move comes at an important time for Paratek, as we have recently initiated a global Phase 3 program for our lead antibiotic compound, omadacycline. With two important products in Phase 3 clinical studies, we are now preparing for the next phase of our growth as a biopharmaceutical company,” said Michael Bigham, chairman and chief executive officer, Paratek. “The company takes pride in its origins as a Boston-based biopharmaceutical company, and we look forward to our continued growth here in Boston.”

The address of the new headquarters is 75 Park Plaza, 4th floor, Boston, MA 02116. Paratek was previously located at 75 Kneeland Street in Boston. In June Paratek opened a second office location in the Philadelphia area.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics